<DOC>
	<DOCNO>NCT02987491</DOCNO>
	<brief_summary>Obesity associate decrease skeletal muscle insulin sensitivity . Aerobic exercise increase insulin sensitivity hour follow exercise , however cellular mechanism completely understood . The current project investigate mechanism exercise improvement skeletal muscle insulin sensitivity .</brief_summary>
	<brief_title>Exercise Insulin Signaling Human Skeletal Muscle</brief_title>
	<detailed_description>Study Overview : We investigate mechanism exercise improve response skeletal muscle insulin lean obese adult . Participants complete 4 study visit consist : 1 ) screen visit , 2 ) maximal exercise test visit , randomize order 3 ) rest metabolic study visit , 4 ) exercise metabolic study visit . Metabolic study visit rest exercise condition identical , remain sedentary performing exercise . Skeletal muscle biopsy sample collect resting , immediately post-exercise insulin stimulate condition .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Males Females Aged 1845 year Normal weight ( body mass index [ BMI ] 1825 kg/m2 ) obese ( BMI 3040 kg/m2 ) Sedentary ( &lt; 1 hour plan physical activity per week ≥ 6 month ) Weight stable ( &lt; 2 kg change body mass ≥ 6 month ) Nonsmokers ( tobacco nicotine use ≥ 1 year ) Hypertension ( systolic blood pressure &gt; 140 mmHg , diastolic blood pressure &gt; 90mmHg ) Chronic health condition include diabetes , cardiovascular disease , treat hypertension , cancer , anemia , uncontrolled hyper hypothyroidism . Pregnant , nursing , irregular menses postmenopausal ( female ) Hyperglycemia ( fast glucose &gt; 126 mg/dl ) Hypercholesterolemia ( fast LDL &gt; 140mg/dl ) Hemoglobin &lt; 13.0 g/dl ( male ) , &lt; 11.5 g/dl ( female ) Compromised renal function ( outside 135145 mmol/L sodium , 3.55.1 mmol/L potassium ) Lidocaine allergy Medications include βblockers , angiotensin convert enzyme inhibitor , insulin , thiazolidinediones , metformin , sulfonylurea , chronic nonsteroidal antiinflammatory use , anticoagulant ( e.g . warfarin ) , current antibiotic , opiate , monoamine oxidase inhibitor , benzodiazepine , others may impact study outcome Any physical limitation prevents participant safely complete exercise test Due risk associate current protocol , individual diminish capacity consent exclude . Similarly , due need constant , accurate participant monitor metabolic study activity , participant need clearly understand verbal write English . Participants clearly understand verbal write English exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>exercise</keyword>
</DOC>